Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T10:26:57.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated to version 2.14.1 on January 13, 2025, following the removal of version 2.14.0 on December 16, 2024.
    Difference
    1%
    Check dated 2025-01-20T01:29:40.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T20:38:18.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new addition was made on December 16, 2024, while there were deletions on November 13, 2024.
    Difference
    0.6%
    Check dated 2024-12-22T06:30:43.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T23:12:09.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T18:39:54.000Z thumbnail image

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.